A study evaluating pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ledipasvir; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 02 Nov 2017 New trial record